IP Library Granted Patent US 7,465,848
Granted Patent B2
US 7,465,848 · App. 11/149,662 · Granted Dec 16, 2008

Zebrafish assay

Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,465,848
App. No.
11/149,662
Granted
Dec 16, 2008
Kind
B2
Abstract

The invention includes a zebrafish assay for cardiac response.

Claims (41)

1. A method of evaluating a test agent for the ability to modulate a parameter of heart function in a mammal, the method comprising:

(a) introducing a calcium-responsive molecule to a zebrafish heart, wherein the calcium-responsive molecule is not expressed from a transgene;

(b) contacting the zebrafish heart with a test agent; and

(c) evaluating a calcium-based parameter of heart function in the zebrafish heart, wherein modulation of the parameter compared to the parameter evaluated in the absence of the test agent is an indication that the test agent has the ability to modulate a parameter of heart function in a mammal.

2. The method of claim 1 , further comprising: (d) correlating the effect of the agent on the parameter of heart function in the zebrafish with a predicted effect on heart function in a mammal.

3. A method of evaluating a test agent for the ability to modulate a parameter of heart function in a mammal, the method comprising:

(a) introducing a calcium-responsive molecule to a zebrafish heart, wherein the calcium-responsive molecule is not expressed from a transgene;

(b) contacting the zebrafish heart with a test agent; and

(c) evaluating a parameter of heart function in the zebrafish heart, wherein the parameter is an assessment of a calcium transient, wherein modulation of the parameter compared to the parameter evaluated in the absence of the test agent is an indication that the test agent has the ability to modulate a parameter of heart function in a mammal.

4. The method of claim 3 , wherein the parameter is an assessment of the time for 90% completion of the calcium transient.

5. The method of claim 3 , wherein the parameter is an assessment of calcium transient amplitude.

6. The method of claim 1 , wherein the zebrafish is a wild-type zebrafish larva.

7. The method of claim 1 , wherein the zebrafish is a zebrafish larva.

8. The method of claim 1 , further comprising contacting the zebrafish heart with a second test agent.

9. The method of claim 1 , wherein the method is performed in an array format.

10. A method of evaluating a test agent for the ability to modulate a parameter of heart function in a mammal, the method comprising:

(a) contacting a zebrafish heart with a test agent, wherein the heart includes cells that comprise a calcium-responsive molecule, wherein the calcium responsive molecule is a detectable marker protein or a dye, and wherein the calcium-responsive molecule is not expressed from a transgene; and

(b) evaluating a calcium-based parameter of heart function in the zebrafish heart, wherein modulation of the parameter compared to the parameter evaluated in the absence of the test agent is an indication that the test agent has the ability to modulate a parameter of heart function in a mammal.

11. The method of claim 1 , further comprising permeabilizing the zebrafish prior to or concurrently with step (a), step (b), or step (c).

12. The method of claim 1 , wherein the test agent is evaluated in combination with a second test agent.

13. The method of claim 1 , wherein the test agent is a small molecule.

14. The method of claim 1 , wherein the test agent is a protein.

15. The method of claim 1 , wherein the heart is evaluated within an intact zebrafish.

16. The method of claim 1 , wherein a plurality of compounds is evaluated, at least some of which are evaluated in parallel.

17. The method of claim 1 , wherein the calcium responsive molecule is administered to a zebrafish larva prior to or concurrently with the step of contacting.

18. The method of claim 17 , wherein the calcium responsive molecule is administered topically.

19. The method of claim 17 , wherein the calcium responsive molecule is administered by injection.

20. The method of claim 1 , wherein the calcium responsive molecule is injected aequorin.

21. The method of claim 10 , wherein the detectable marker protein is aequorin.

22. The method of claim 1 , further comprising:

evaluating a parameter of heart function selected from heart rate, blood flow, contraction fraction, ejection fraction, repolarization, calcium flux, calcium concentration, conduction velocity, presence of an atrioventricular (AV) block, and QT interval, in the zebrafish heart.

23. The method of claim 10 , further comprising:

evaluating a parameter of heart function selected from heart rate, blood flow, contraction fraction, ejection fraction, repolarization, calcium flux, calcium concentration, conduction velocity, presence of an atrioventricular (AV) block, and QT interval, in the zebrafish heart.

24. The method of claim 1 , further comprising:

introducing a voltage-sensitive dye to the zebrafish heart; and

visualizing the voltage-sensitive dye.

25. The method of claim 10 , further comprising:

contacting the zebrafish heart with a voltage-sensitive dye; and

visualizing the voltage-sensitive dye.

26. The method of claim 1 , wherein the calcium-responsive molecule is selected from the group consisting of calcium green, fura-2, indo-1, and fluo-3.

27. The method of claim 10 , wherein the calcium-responsive dye is selected from the group consisting of calcium green, fura-2, indo-1, and fluo-3.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 9, 2022
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061702/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2005
From: MACRAE, CALUM A.; MILAN, DAVID J.; BURNS, C. GEOFFREY; PETERSON, RANDALL; PETERSON, TRAVIS
To: GENERAL HOSPITAL CORPORATION, THE
Reel/Frame 016841/0167 →
Continuity (3)
Continuation In Part 1060541500 · Sep 29, 2003
Provisional Application 6042775300 · Nov 20, 2002
Related Publication 20060015948A1 · Jan 19, 2006